Caffeine doesn't create energy—it blocks the fatigue signal. Your tiredness keeps accumulating; you just can't feel it. And whether this matters depends on y…
#Caffeine #Cardiovascularhealth #CYP1A2 #Personalizedmedicine #Pharmacogenomics
#Caffeine #Cardiovascularhealth #CYP1A2 #Personalizedmed…
#Caffeine #Cardiovascularhealth #CYP1A2 #Personalizedmedicine #Pharmacogenomics
#Caffeine #Cardiovascularhealth #CYP1A2 #Personalizedmed…
Caffeine Doesn't Give Energy—It Masks Fatigue
Caffeine doesn't create energy—it blocks the fatigue signal. Your tiredness keeps accumulating; you just can't feel it. And whether this matters depends on y…
#Caffeine #Cardiovascularhealth #CYP1A2 #Personalizedmedicine #Pharmacogenomics
news.gmj.ge
October 6, 2026 at 5:27 PM
Caffeine doesn't create energy—it blocks the fatigue signal. Your tiredness keeps accumulating; you just can't feel it. And whether this matters depends on y…
#Caffeine #Cardiovascularhealth #CYP1A2 #Personalizedmedicine #Pharmacogenomics
#Caffeine #Cardiovascularhealth #CYP1A2 #Personalizedmed…
#Caffeine #Cardiovascularhealth #CYP1A2 #Personalizedmedicine #Pharmacogenomics
#Caffeine #Cardiovascularhealth #CYP1A2 #Personalizedmed…
Our upcoming webinar is a case study on therapeutic response examining glycemic response, side effects, and the influence of germline variants on these with our partners Ovation. Register: event.on24.com/wcc/r/549955...
#GLP1 #Pharmacogenomics #PrecisionMedicine #Genomics #DNAnexus
#GLP1 #Pharmacogenomics #PrecisionMedicine #Genomics #DNAnexus
October 6, 2026 at 4:39 PM
Our upcoming webinar is a case study on therapeutic response examining glycemic response, side effects, and the influence of germline variants on these with our partners Ovation. Register: event.on24.com/wcc/r/549955...
#GLP1 #Pharmacogenomics #PrecisionMedicine #Genomics #DNAnexus
#GLP1 #Pharmacogenomics #PrecisionMedicine #Genomics #DNAnexus
New recommendations on returning secondary genomic findings to research participants, including polygenic risk scores and pharmacogenomics.
The focus is also on equity, community engagement and the practicalities of returning results at scale 🧬.
www.nature.com/articles/s41...
The focus is also on equity, community engagement and the practicalities of returning results at scale 🧬.
www.nature.com/articles/s41...
October 6, 2026 at 6:30 AM
New recommendations on returning secondary genomic findings to research participants, including polygenic risk scores and pharmacogenomics.
The focus is also on equity, community engagement and the practicalities of returning results at scale 🧬.
www.nature.com/articles/s41...
The focus is also on equity, community engagement and the practicalities of returning results at scale 🧬.
www.nature.com/articles/s41...
Pharmacogenomics asks whether genetic differences could help explain why a medicine works for one person but not another. It can inform choice or dose for some medicines—not all—and never replaces the full clinical picture. Would you choose DNA or NOT YET? #Pharmacogenomics
October 5, 2026 at 6:26 PM
Pharmacogenomics asks whether genetic differences could help explain why a medicine works for one person but not another. It can inform choice or dose for some medicines—not all—and never replaces the full clinical picture. Would you choose DNA or NOT YET? #Pharmacogenomics
🔬 From genomics to prescribing practice…
What needs to happen before genomics-informed medicines optimisation becomes routine?
Explore the opportunities and implementation challenges in infection with UKCPA.
ukclinicalpharmacy.org/event/genomi...
What needs to happen before genomics-informed medicines optimisation becomes routine?
Explore the opportunities and implementation challenges in infection with UKCPA.
ukclinicalpharmacy.org/event/genomi...
Genomics-informed medicines optimisation and applications in infection - UKCPA
Genomics is a key element of the recent NHS 10 Year Plan, along with a pledge to incorporate pharmacogenomics (PGx) into routine clinical
ukclinicalpharmacy.org
October 4, 2026 at 10:34 AM
🔬 From genomics to prescribing practice…
What needs to happen before genomics-informed medicines optimisation becomes routine?
Explore the opportunities and implementation challenges in infection with UKCPA.
ukclinicalpharmacy.org/event/genomi...
What needs to happen before genomics-informed medicines optimisation becomes routine?
Explore the opportunities and implementation challenges in infection with UKCPA.
ukclinicalpharmacy.org/event/genomi...
Upgrading the home setup?
The Tassle With Pharmacogenomics Education Subject Coffee Mug
https://www.amazon.com/dp/B0HLH5R9G6?tag=choosetoshop-20
#AmazonAffiliate #ad #CoffeeMug #BaristaLife
The Tassle With Pharmacogenomics Education Subject Coffee Mug
https://www.amazon.com/dp/B0HLH5R9G6?tag=choosetoshop-20
#AmazonAffiliate #ad #CoffeeMug #BaristaLife
The Tassle With Pharmacogenomics Education Subject Coffee Mug
Coffee gear pick — price and reviews are on Amazon.
www.amazon.com
September 30, 2026 at 11:03 AM
Upgrading the home setup?
The Tassle With Pharmacogenomics Education Subject Coffee Mug
https://www.amazon.com/dp/B0HLH5R9G6?tag=choosetoshop-20
#AmazonAffiliate #ad #CoffeeMug #BaristaLife
The Tassle With Pharmacogenomics Education Subject Coffee Mug
https://www.amazon.com/dp/B0HLH5R9G6?tag=choosetoshop-20
#AmazonAffiliate #ad #CoffeeMug #BaristaLife
In this blog article, #AdrushaRamsunder and #RachelPalmer explore what progress has been made towards a genomics population health service, what challenges need to be overcome and what is the role of pharmacy?
#ukpharmacy #pharmacogenomics
buff.ly/8rOSfXf
#ukpharmacy #pharmacogenomics
buff.ly/8rOSfXf
Genomics implementation in practice: opportunities, progress and challenges
Genomics is now an established area of the NHS, rather than a purely aspirational idea. In England, the NHS Genomic Medicine Service (GMS) — established in 2018 — has been tasked with implementing…
buff.ly
September 29, 2026 at 6:00 PM
In this blog article, #AdrushaRamsunder and #RachelPalmer explore what progress has been made towards a genomics population health service, what challenges need to be overcome and what is the role of pharmacy?
#ukpharmacy #pharmacogenomics
buff.ly/8rOSfXf
#ukpharmacy #pharmacogenomics
buff.ly/8rOSfXf
The authors of a new article review the ways in which polygenic risk scores, along with the related field of pharmacogenomics, may be useful in clinical practice for the prevention and treatment of common diseases. Read the full article: https://nej.md/4Amwv0F
September 29, 2026 at 4:00 PM
The authors of a new article review the ways in which polygenic risk scores, along with the related field of pharmacogenomics, may be useful in clinical practice for the prevention and treatment of common diseases. Read the full article: https://nej.md/4Amwv0F
Exciting new review from @mikeinouye.bsky.social & Prof David Hunter in @nejm.org
Their review explores how polygenic risk scores and pharmacogenomics could translate genomic insights into clinical practice, improving prevention and treatment of common diseases.
Read more here tinyurl.com/4v9mbmd4
Their review explores how polygenic risk scores and pharmacogenomics could translate genomic insights into clinical practice, improving prevention and treatment of common diseases.
Read more here tinyurl.com/4v9mbmd4
September 29, 2026 at 1:02 PM
Exciting new review from @mikeinouye.bsky.social & Prof David Hunter in @nejm.org
Their review explores how polygenic risk scores and pharmacogenomics could translate genomic insights into clinical practice, improving prevention and treatment of common diseases.
Read more here tinyurl.com/4v9mbmd4
Their review explores how polygenic risk scores and pharmacogenomics could translate genomic insights into clinical practice, improving prevention and treatment of common diseases.
Read more here tinyurl.com/4v9mbmd4
💊 Could your genes help inform medicines choices?
Join UKCPA to explore pharmacogenomics, antimicrobial applications & the role of genomics in infection.
A practical look at where genomics-informed medicines optimisation could be heading.
📅 29 Oct | 1–2pm
ukclinicalpharmacy.org/event/genomi...
Join UKCPA to explore pharmacogenomics, antimicrobial applications & the role of genomics in infection.
A practical look at where genomics-informed medicines optimisation could be heading.
📅 29 Oct | 1–2pm
ukclinicalpharmacy.org/event/genomi...
Genomics-informed medicines optimisation and applications in infection - UKCPA
Genomics is a key element of the recent NHS 10 Year Plan, along with a pledge to incorporate pharmacogenomics (PGx) into routine clinical
ukclinicalpharmacy.org
September 29, 2026 at 10:34 AM
💊 Could your genes help inform medicines choices?
Join UKCPA to explore pharmacogenomics, antimicrobial applications & the role of genomics in infection.
A practical look at where genomics-informed medicines optimisation could be heading.
📅 29 Oct | 1–2pm
ukclinicalpharmacy.org/event/genomi...
Join UKCPA to explore pharmacogenomics, antimicrobial applications & the role of genomics in infection.
A practical look at where genomics-informed medicines optimisation could be heading.
📅 29 Oct | 1–2pm
ukclinicalpharmacy.org/event/genomi...
AetherXeno: an allele-resolved receptor-occupancy atlas for regulatory pharmacogenomics https://www.biorxiv.org/content/10.64898/2026.09.20.752952v1
September 25, 2026 at 5:45 PM
AetherXeno: an allele-resolved receptor-occupancy atlas for regulatory pharmacogenomics https://www.biorxiv.org/content/10.64898/2026.09.20.752952v1
AetherXeno: an allele-resolved receptor-occupancy atlas for regulatory pharmacogenomics https://www.biorxiv.org/content/10.64898/2026.09.20.752952v1
September 25, 2026 at 5:45 PM
AetherXeno: an allele-resolved receptor-occupancy atlas for regulatory pharmacogenomics https://www.biorxiv.org/content/10.64898/2026.09.20.752952v1
Pharmacogenomics is such a promising step toward more personalized medicine, understanding how genetics affects drug response can help make treatments safer and more effective. 🧬💊
Discover our new pharmacogenomics webpage, featuring information on how genetic variation can influence a response to medicines. Explore data from centrally authorised medicines and scientific guidance for medicine developers 🔗 www.ema.europa.eu/en/human-reg... #PublicHealth #medsky 🧪 #SciComm
Pharmacogenomics | European Medicines Agency (EMA)
Information on pharmacogenomics, including pharmacogenomic information in centrally authorised medicines and scientific guidelines for medicine developers.
www.ema.europa.eu
September 24, 2026 at 1:14 PM
Pharmacogenomics is such a promising step toward more personalized medicine, understanding how genetics affects drug response can help make treatments safer and more effective. 🧬💊
Discover our new pharmacogenomics webpage, featuring information on how genetic variation can influence a response to medicines. Explore data from centrally authorised medicines and scientific guidance for medicine developers 🔗 www.ema.europa.eu/en/human-reg... #PublicHealth #medsky 🧪 #SciComm
Pharmacogenomics | European Medicines Agency (EMA)
Information on pharmacogenomics, including pharmacogenomic information in centrally authorised medicines and scientific guidelines for medicine developers.
www.ema.europa.eu
September 24, 2026 at 8:17 AM
Discover our new pharmacogenomics webpage, featuring information on how genetic variation can influence a response to medicines. Explore data from centrally authorised medicines and scientific guidance for medicine developers 🔗 www.ema.europa.eu/en/human-reg... #PublicHealth #medsky 🧪 #SciComm
Genomic medicine is moving from “What disease do you have?” toward “What is going wrong in this person, in this tissue, right now?” More:
Genomic Medicine, Stem Cells and Health | The Genomic Power Shift
Precision medicine, pharmacogenomics and stem cell therapies are rewriting how we treat disease. Part 4 of The Genomic Power Shift by Magdalena Zarowiecki.
thegenomicpowershift.org
September 24, 2026 at 7:45 AM
Genomic medicine is moving from “What disease do you have?” toward “What is going wrong in this person, in this tissue, right now?” More:
A genomic test can be technically accurate and still be clinically useless. Accuracy, interpretation and usefulness are different things. More:
Genomic Medicine, Stem Cells and Health | The Genomic Power Shift
Precision medicine, pharmacogenomics and stem cell therapies are rewriting how we treat disease. Part 4 of The Genomic Power Shift by Magdalena Zarowiecki.
thegenomicpowershift.org
September 23, 2026 at 5:24 PM
A genomic test can be technically accurate and still be clinically useless. Accuracy, interpretation and usefulness are different things. More:
🦠 Genomics + infection = new possibilities for pharmacy practice.
Explore how genomics could support antimicrobial medicines optimisation, infection diagnosis & future prescribing pathways.
📅 29 Oct | 1–2pm
💻 Online
🎟️ Members FREE | Guests £35
ukclinicalpharmacy.org/event/genomi...
Explore how genomics could support antimicrobial medicines optimisation, infection diagnosis & future prescribing pathways.
📅 29 Oct | 1–2pm
💻 Online
🎟️ Members FREE | Guests £35
ukclinicalpharmacy.org/event/genomi...
Genomics-informed medicines optimisation and applications in infection - UKCPA
Genomics is a key element of the recent NHS 10 Year Plan, along with a pledge to incorporate pharmacogenomics (PGx) into routine clinical
ukclinicalpharmacy.org
September 23, 2026 at 10:34 AM
🦠 Genomics + infection = new possibilities for pharmacy practice.
Explore how genomics could support antimicrobial medicines optimisation, infection diagnosis & future prescribing pathways.
📅 29 Oct | 1–2pm
💻 Online
🎟️ Members FREE | Guests £35
ukclinicalpharmacy.org/event/genomi...
Explore how genomics could support antimicrobial medicines optimisation, infection diagnosis & future prescribing pathways.
📅 29 Oct | 1–2pm
💻 Online
🎟️ Members FREE | Guests £35
ukclinicalpharmacy.org/event/genomi...
Holistic oncology care requires looking closely at drug-drug interactions. This latest blog from Rorisang Moletsane highlights how certain antidepressants can dampen Tamoxifen efficacy in ER+ breast cancer patients. 🔬📚
healthsciencereviews.com/2026/09/22/b...
#SciComm #UCT #Pharmacogenomics
healthsciencereviews.com/2026/09/22/b...
#SciComm #UCT #Pharmacogenomics
September 22, 2026 at 6:56 PM
Holistic oncology care requires looking closely at drug-drug interactions. This latest blog from Rorisang Moletsane highlights how certain antidepressants can dampen Tamoxifen efficacy in ER+ breast cancer patients. 🔬📚
healthsciencereviews.com/2026/09/22/b...
#SciComm #UCT #Pharmacogenomics
healthsciencereviews.com/2026/09/22/b...
#SciComm #UCT #Pharmacogenomics
A cure only a few people can access is still a crisis. Genomic medicine can work scientifically and fail economically. More:
Genomic Medicine, Stem Cells and Health | The Genomic Power Shift
Precision medicine, pharmacogenomics and stem cell therapies are rewriting how we treat disease. Part 4 of The Genomic Power Shift by Magdalena Zarowiecki.
thegenomicpowershift.org
September 22, 2026 at 3:03 PM
A cure only a few people can access is still a crisis. Genomic medicine can work scientifically and fail economically. More:
September 22, 2026 at 3:00 PM
Current DPYD genotyping panels explain only a limited share of severe fluoropyrimidine toxicity.
#pharmacogenomics #PGx #genomics
#pharmacogenomics #PGx #genomics
DPYD c.85 T > C, DPYD c.496 A>G, and DPYD c.2194 G>A and severe toxicity to fluoropyrimidines in PREPARE and Alpe-DPD tr
Severe fluoropyrimidine-related toxicity · Pharmacol Res 2026
www.genox-veille.fr
September 21, 2026 at 1:00 PM
Current DPYD genotyping panels explain only a limited share of severe fluoropyrimidine toxicity.
#pharmacogenomics #PGx #genomics
#pharmacogenomics #PGx #genomics
Preventing a devastating inherited disease and selecting a preferred future child are not the same thing — but genomics makes the boundary harder to draw. More:
Genomic Medicine, Stem Cells and Health | The Genomic Power Shift
Precision medicine, pharmacogenomics and stem cell therapies are rewriting how we treat disease. Part 4 of The Genomic Power Shift by Magdalena Zarowiecki.
thegenomicpowershift.org
September 21, 2026 at 10:45 AM
Preventing a devastating inherited disease and selecting a preferred future child are not the same thing — but genomics makes the boundary harder to draw. More:
"Building a Deterministic Pharmacogenomics Engine That Catches What Global Drug Guidelines Miss" by Abhimanyu R B
#aideas-2025 #ai #ai-engineering
#aideas-2025 #ai #ai-engineering
Building a Deterministic Pharmacogenomics Engine That Catches What Global Drug Guidelines Miss
Global drug-safety guidelines are trained almost entirely on European genomic data. Here's how I built an open-source, rule-based engine that flags population-specific drug risks those guidelines miss, and validated it on a real South Asian genome.
community.aws
September 21, 2026 at 7:30 AM
"Building a Deterministic Pharmacogenomics Engine That Catches What Global Drug Guidelines Miss" by Abhimanyu R B
#aideas-2025 #ai #ai-engineering
#aideas-2025 #ai #ai-engineering
Sequencing every newborn sounds obviously beneficial until you ask what should happen to all the information. Would you do it?
Genomic Medicine, Stem Cells and Health | The Genomic Power Shift
Precision medicine, pharmacogenomics and stem cell therapies are rewriting how we treat disease. Part 4 of The Genomic Power Shift by Magdalena Zarowiecki.
thegenomicpowershift.org
September 20, 2026 at 8:25 AM
Sequencing every newborn sounds obviously beneficial until you ask what should happen to all the information. Would you do it?
Mice are useful medical models, but they are not tiny humans wearing fur. Human organoids may change how we study disease. More:
Genomic Medicine, Stem Cells and Health | The Genomic Power Shift
Precision medicine, pharmacogenomics and stem cell therapies are rewriting how we treat disease. Part 4 of The Genomic Power Shift by Magdalena Zarowiecki.
thegenomicpowershift.org
September 19, 2026 at 1:46 PM
Mice are useful medical models, but they are not tiny humans wearing fur. Human organoids may change how we study disease. More: